CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -26.7% | 3,468 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $15,000 | -46.4% | 3,468 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $28,000 | +7.7% | 3,468 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $26,000 | -13.3% | 3,468 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $30,000 | +42.9% | 3,468 | +30.0% | 0.00% | 0.0% |
| Q4 2020 | $21,000 | 0.0% | 2,668 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $21,000 | -19.2% | 2,668 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $26,000 | +23.8% | 2,668 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $21,000 | +110.0% | 2,668 | 0.0% | 0.00% | – |
| Q4 2019 | $10,000 | -23.1% | 2,668 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $13,000 | -27.8% | 2,668 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $18,000 | -10.0% | 2,668 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $20,000 | -9.1% | 2,668 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $22,000 | -35.3% | 2,668 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $34,000 | +13.3% | 2,668 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $30,000 | – | 2,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |